Nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine For The First Line Treatment of Pancreas Cancer

Clinical trial NCT03807999 · COMPLETED

Trial details

NCT number: NCT03807999
Sponsor: Hacettepe University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pancreatic Neoplasm

Start date: 2015-02-19
Primary completion: 2018-04-01
Enrollment: 125

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.